Similarly, targeting GSK3β to restore Beclin-1 expression and LC3B-II conversion in neuronal models may offer a translatable strategy for neurodegenerative diseases, where impaired autophagic flux is a major pathological driver (Joshi et al., 2017; Sophia et al., 2018). Here, BECN1 is linked to neurodegenerative disease.